PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
- PMID: 36359439
- PMCID: PMC9689635
- DOI: 10.3390/diagnostics12112594
PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
Abstract
Prostate cancer is the most common cancer and the second leading cause of cancer death in men. The imaging assessment and treatment of prostate cancer has vastly improved over the past decade. The introduction of PSMA PET-CT has improved the detection of loco-regional and metastatic disease. PSMA PET-CT also has a role in the primary diagnosis and staging, in detecting biochemical recurrence after curative treatment and in metastasis-directed therapy. In this paper we review the role of PSMA PET-CT in prostate cancer.
Keywords: PSMA PET; imaging; prostate cancer.
Conflict of interest statement
The authors declare no conflict of interest.
Figures










Similar articles
-
More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003
-
68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls.Cancer Imaging. 2018 Nov 1;18(1):39. doi: 10.1186/s40644-018-0175-3. Cancer Imaging. 2018. PMID: 30382889 Free PMC article.
-
Recurrence rate after radical prostatectomy following primary staging of high-risk prostate cancer with 68Ga-PSMA PET/CT.Acta Oncol. 2022 Oct;61(10):1289-1294. doi: 10.1080/0284186X.2022.2129442. Epub 2022 Oct 5. Acta Oncol. 2022. PMID: 36199168
-
68Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15. Eur Urol Focus. 2018. PMID: 28753806
-
The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer.Eur Urol Focus. 2021 Mar;7(2):258-266. doi: 10.1016/j.euf.2021.01.016. Epub 2021 Feb 2. Eur Urol Focus. 2021. PMID: 33541838 Review.
Cited by
-
Editorial for Special Topics: Imaging-Based Diagnosis for Prostate Cancer-State of the Art.Diagnostics (Basel). 2024 Sep 12;14(18):2016. doi: 10.3390/diagnostics14182016. Diagnostics (Basel). 2024. PMID: 39335695 Free PMC article.
-
Early Detection of Secondary Bladder Urothelial Carcinoma and Disseminated Bone Metastases with Normal Prostate-Specific Antigen Level after Pelvic Salvage Radiotherapy in Prostate Cancer.Life (Basel). 2023 May 25;13(6):1249. doi: 10.3390/life13061249. Life (Basel). 2023. PMID: 37374033 Free PMC article.
-
High Detection Rates for Prostate-specific Membrane Antigen-avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography.Eur Urol Open Sci. 2024 Dec 7;71:49-56. doi: 10.1016/j.euros.2024.11.008. eCollection 2025 Jan. Eur Urol Open Sci. 2024. PMID: 39720335 Free PMC article.
-
Isolated Lung Metastasis Prostate Cancer.Ann Med Surg (Lond). 2025 Mar 18;87(6):3842-3846. doi: 10.1097/MS9.0000000000003204. eCollection 2025 Jun. Ann Med Surg (Lond). 2025. PMID: 40486571 Free PMC article.
-
Evaluating the Initial Experience and Clinical Impact of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Scans in Prostate Cancer Management: A Retrospective Study in Iraq.Cureus. 2024 Aug 26;16(8):e67814. doi: 10.7759/cureus.67814. eCollection 2024 Aug. Cureus. 2024. PMID: 39323677 Free PMC article.
References
-
- Royal Australian College of General Practitioners. National Preventive and Community Medicine Committee . Guidelines for Preventive Activities in General Practice. 9th ed. RACGP; East Melbourne, Australia: 2016. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous